Mitogen Activated Protein kinase signal transduction pathways in the prostate

Cell Communication and Signaling : CCS
Paul D MaroniHari K Koul

Abstract

The biochemistry of the mitogen activated protein kinases ERK, JNK, and p38 have been studied in prostate physiology in an attempt to elucidate novel mechanisms and pathways for the treatment of prostatic disease. We reviewed articles examining mitogen-activated protein kinases using prostate tissue or cell lines. As with other tissue types, these signaling modules are links/transmitters for important pathways in prostate cells that can result in cellular survival or apoptosis. While the activation of the ERK pathway appears to primarily result in survival, the roles of JNK and p38 are less clear. Manipulation of these pathways could have important implications for the treatment of prostate cancer and benign prostatic hypertrophy.

References

Dec 24, 1997·Oncogene·A W GrassoH J Kung
Jun 30, 1998·Virchows Archiv : an International Journal of Pathology·C Magi-GalluzziM Loda
Feb 18, 1999·Journal of Cellular Biochemistry·R K RaviM Mabry
Sep 24, 1999·The Journal of Urology·D T PriceL M Luttrell
Dec 22, 1999·Oncogene·H PeterzielA C Cato
Jul 6, 2000·Journal of the National Cancer Institute·E A ShetaD Theodorescu
Nov 4, 2000·The Journal of Urology·P F Kue, Y Daaka
Feb 27, 2001·Toxicological Sciences : an Official Journal of the Society of Toxicology·D M Tessier, F Matsumura
May 24, 2001·The Journal of Urology·L Barki-Harrington, Y Daaka
Jun 1, 2001·The Journal of Steroid Biochemistry and Molecular Biology·P TuohimaaT Ylikomi
Aug 30, 2001·Hematology/oncology Clinics of North America·B R Konety, J B Nelson
Nov 3, 2001·Matrix Biology : Journal of the International Society for Matrix Biology·J A Kiefer, M C Farach-Carson
Feb 8, 2002·The Journal of Urology·Ganesh V RajYehia Daaka
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Sompol PermpongkosolAkihiko Okuyama
Jun 19, 2002·Biochimica Et Biophysica Acta·Yehia Daaka
Jun 27, 2002·The Journal of Biological Chemistry·Yuhuan XieKathryn E Meier
Sep 26, 2002·The Journal of Biological Chemistry·Cai BowenEdward P Gelmann
Nov 6, 2002·FEBS Letters·Shizhong BuMaréne Landström
Nov 15, 2002·Molecular and Cellular Endocrinology·Zoran CuligAlfred Hobisch
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Pao F KueYehia Daaka
Dec 11, 2002·The Journal of Biological Chemistry·Jian ZhouJer-Tsong Hsieh

❮ Previous
Next ❯

Citations

Jul 2, 2014·BioMed Research International·Georgios ChondrogiannisVasiliki Galani
Feb 16, 2008·BMC Medical Genomics·Zongbing YouJonathan Melamed
Jan 2, 2007·Biochemical and Biophysical Research Communications·Yohei ShidaHiroshi Kanetake
Jan 3, 2006·Critical Reviews in Oncology/hematology·C GennigensJ P Droz
Feb 15, 2018·Endocrinology·Takako KawanamiTosihiko Yanase
Feb 5, 2011·Urologia Internationalis·Ricarda M BauerMartin Hennenberg
Sep 17, 2013·Neurourology and Urodynamics·Martin HennenbergChristian Gratzke
Sep 8, 2020·BMC Endocrine Disorders·Qiao-Yan DingXiong Wang
Sep 11, 2019·International Journal of Molecular Sciences·Wen-Chin HuangMing-Ching Kao
May 10, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Xiong WangJin-Hu Wu
Mar 23, 2018·Pathology Oncology Research : POR·I GkouverisA Sklavounou
Apr 25, 2018·Mediators of Inflammation·Wen-Yao ZhangMing-Qing Gao
May 11, 2018·Regenerative Medicine·Anuradha VaidyaSuprita Ghode
Jan 16, 2020·Current Pharmaceutical Design·Sabah NisarAjaz A Bhat
Oct 17, 2008·Molecular Cancer Research : MCR·Thomas R JohnsonHari K Koul
Mar 17, 2007·Molecular Cancer Therapeutics·Athanasios G PapatsorisAthanasios G Papavassiliou
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anthony H YehLisa K Chopin
Feb 3, 2009·Cancer Letters·Lakshmipathi KhandrikaHari K Koul
Jun 8, 2011·Differentiation; Research in Biological Diversity·Ming JiangSimon W Hayward

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis